Correspondence 0001641172-25-003293 from ZyVersa Therapeutics, Inc. (ZVSA)
ZyVersa Therapeutics, Inc.
Date: April 8, 2025 · CIK: 0001859007 · Accession: 0001641172-25-003293
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286396
Letter
Re: ZyVersa Therapeutics, Inc. (the " Company ") Registration Statement on Form S-3 (File No. 333-286396) (the " Registration Statement ")
ZyVersa Therapeutics, Inc.
N. Commerce Parkway, Suite 208
Weston, Florida 33326
(754) 231-1688
April 8, 2025
VIA EDGAR SUBMISSION
U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended , the Company hereby requests that the U.S. Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement to become effective on Wednesday, April 9, 2025, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable, unless the Company notifies you otherwise prior to such time.
If you have any questions regarding this request, please contact our outside counsel, Faith Charles of Thompson Hine LLP, by telephone at (212) 908-3905 or via email at Faith.Charles@ThompsonHine.com. Please also call Faith Charles as soon as the Company's Registration Statement has been declared effective. Thank you for your attention to this matter.
Sincerely,
ZYVERSA THERAPEUTICS, Inc.
Show Raw Text
CORRESP 1 filename1.htm ZyVersa Therapeutics, Inc. 2200 N. Commerce Parkway, Suite 208 Weston, Florida 33326 (754) 231-1688 April 8, 2025 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: ZyVersa Therapeutics, Inc. (the " Company ") Registration Statement on Form S-3 (File No. 333-286396) (the " Registration Statement ") Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended , the Company hereby requests that the U.S. Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement to become effective on Wednesday, April 9, 2025, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable, unless the Company notifies you otherwise prior to such time. If you have any questions regarding this request, please contact our outside counsel, Faith Charles of Thompson Hine LLP, by telephone at (212) 908-3905 or via email at Faith.Charles@ThompsonHine.com. Please also call Faith Charles as soon as the Company's Registration Statement has been declared effective. Thank you for your attention to this matter. Sincerely, ZYVERSA THERAPEUTICS, Inc. By: /s/ Stephen C. Glover Name: Stephen C. Glover Title: Chief Executive Officer cc: Faith Charles, Thompson Hine LLP